Related Experiment Video

Updated: May 30, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Plasma leptin and adiponectin concentrations in healthy, non-obese children

Helena I Papaioannou1, Dimitrios A Stakos, Dimitrios N Tziakas

  • 1Department of Pediatrics, Democritus University of Thrace, Alexandroupolis, Greece.

Journal of Pediatric Endocrinology & Metabolism : JPEM
|August 10, 2011
PubMed

Insights

Childhood growth, parental smoking, and obesity impact leptin and adiponectin levels. Early interventions targeting families may improve adipocytokine profiles in healthy children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Adipokine Signaling

Background:

  • Altered plasma leptin and adiponectin concentrations are linked to adverse metabolic profiles in obese children.
  • Understanding factors influencing these adipokines in healthy children is crucial for early metabolic health assessment.

Purpose of the Study:

  • To investigate multiple factors affecting plasma leptin and adiponectin in healthy, non-obese children.
  • To assess the influence of growth indices, physical activity, and parental characteristics on adipokine levels.

Main Methods:

  • Study included 170 healthy non-obese children with birth records.
  • Plasma leptin and adiponectin measured via immunoassay.
  • Weight-for-birth-weight ratio (WBWR), physical activity, and parental factors were assessed.

Main Results:

  • Leptin positively correlated with WBWR; parental smoking and obesity were negatively associated with breastfeeding and exercise access.
  • Adiponectin negatively correlated with WBWR and parental smoking.
  • Parental obesity and smoking had an additive negative effect on adiponectin levels.

Conclusions:

  • Childhood and parental factors significantly influence leptin and adiponectin concentrations in healthy children.
  • Early, family-centered preventive strategies can potentially improve adipocytokine profiles.
  • This research highlights the interconnectedness of family environment and pediatric metabolic markers.
Abstract

More Related Videos

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro10:40

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...